对于突变TP53的神经髓瘤的非移植治疗方法
Ansh K Mehta1, Marina Konopleva2
1Department of Hematology and Oncology, Jacobi Medical Center/Albert Einstein College of Medicine, Bronx, NY.
Hematology. American Society of Hematology. Education Program
|December 7, 2024
概括
像MDS和AML这样的TP53突变骨髓状细胞疾病是侵略性的,并且对标准治疗有抗性. 新兴疗法为改善这些具有挑战性的条件下生存率提供了新的希望.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 突变TP53的骨髓质疏松综合征 (MDS) 和急性骨髓性白血病 (AML) 是具有不良预后的侵袭性克隆性骨髓性疾病.
- 双性TP53损失导致一种主导的,高度攻击性的,耐化疗的TP53突变克隆.
- 2022年国际共识分类将其指定为"带有突变TP53的骨髓细胞疾病".
研究的目的:
- 审查特征为TP53突变的髓状细胞疾病的当前治疗策略.
- 为提供目前正在开发的新型非移植治疗方法的概述.
主要方法:
- 对TP53突变骨髓瘤恶性瘤的当前和新兴疗法的文献综述.
- 分析针对性疗法和免疫疗法的最新进展.
主要成果:
- 目前的治疗方式并没有显著改善TP53突变骨髓性疾病的存活率.
- 一些有前途的新疗法正在开发中,包括CAR T/NK细胞疗法,p53活性剂和基于抗体的向治疗.
结论:
- 带有TP53突变的髓状细胞疾病仍然是一个重要的临床挑战,治疗选择有限.
- 新兴的非移植方法显示出在这个患者群体中改善结果的潜力.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy
476
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
476
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Bone Marrow Sampling and Transplants
284
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
284
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


